The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes

Experimental Nephrology

Volumn 4, Issue SUPPL. 1, 1996, Pages 53-60

  Ruggenenti, Piero ^a,b   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

ACE inhibitors; Chronic nephropathies; Diabetes mellitus, insulin dependent; Diabetes mellitus, non insulin dependent; Diabetic nephropathy; Microalbuminuria; Proteinuria

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; LISINOPRIL; NIFEDIPINE;

CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; HUMAN; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; RENAL CIRCULATION;

EID: 0029768425     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990;38: 384.
2. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318: 1657-1666.
3. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981; 241:F85.
4. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 1982;22:112-126.
5. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression: In proteinuric nephropathies enhanced glomerular protein traffic contribules to interstitial inflammation and renal scarring. Kidney Int, in press.
6. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925.
7. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85: 541.
8. Morelli E, Loon N, Meyer TW, Myers BD: Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990;39:76.
9. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 1993;6:36.
10. Remuzzi A, Pertinucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991;39:1267.
11. Harris DCH, Chen L, Tay C, Chen J, Nankivell BJ: Cytotoxicity of reabsorbed protein in proximal tubule (PT) by peroxidation (abstract). J Am Soc Nephrol 1994;5:944.
12. Alfrey AC, Froment DH, Hammond WS: Role of iron in tubulointerstitial injury in nephrotoxic serum nephritis. Kidney Int 1989;36: 753-759.
13. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco PM, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26:934-941.
14. Harris DCH, Chen J: Monocyte chemoattractant protein-1 (MCP-1) mRNA expression in response to protein in rat proximal tubular cells in culture (abstract). J Am Soc Nephrol 1995;6: 1015.
15. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987;294: 1443.
16. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992;304:339.
17. Hommel E, Parving HH, Mathiesen E, Edsberg B, Damjaer M, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986;293: 467.
18. Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetes with nephropathy. BMJ 1988;297:1086.
19. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF: Effects of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 1993;118: 129.
20. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456.
21. Breyer JA: Medical management of nephropathy in type 1 diabetes mellitus: Current recommendations. J Am Soc Nephrol 1995;6:1523-1529.
22. Hommel E, Jensen B, Parving H-H: Long term effect of captopril on kidney function in normotensive insulin dependent diabetic patients (IDDM) with diabetic nephropathy (abstract). J Am Soc Nephrol 1995;6:450.
23. Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Blouch K, Mitch WE: Progression of overt nephropathy in noninsulin-dependent diabetes. Kidney Int 1995;4: 1781-1789.
24. Bakris GL, Copley JB, Vichnair N: Blood pressure reduction and progression of diabetic nephropathy in African Americans (AA) (abstract). J Am Soc Nephrol 1995;6:446.
25. Bakris GL, Copley JB, Vichnair N, Leurgans S: Effect of nondihydropyridine calcium antagonists (NDCAs) on progression of nephropathy from noninsulin dependent diabetes (NIDDM): A five-year follow up study (abstract). J Am Soc Nephrol 1995;6:446.
26. Lebovitz HE, Weigmann TB, Cnaan A, Shaminfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R: Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria. Kidney Int 1994;45: S150.
27. Bakris GL, Copley B, Vicknair N, Sadler R, Leurgans S: Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy: Results of a six-year study. Kidney Int, in press.
28. Campbell O, A M, Parham M, You W, Macon E, Guasch A: Short-term comparison of ACE inhibition vs. calcium channel blockade in African-Americans with type II diabetes mellitus and nephropathy (abstract). J Am Soc Nephrol 1995;6:447.
29. Christensen CK, Mogensen CE: Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension 1985; 7(suppl II):109.
30. Marre M, Le Blanc H, Suarez L: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987;294:1448.
31. Mathiesen ER, Hommel E, Smidt UM, Parving H: Efficacy of captopril in normotensive diabetic patients with microalbuminuria - 8 years follow-up (abstract). J Am Soc Nephrol 1995;6:452.
32. Viberti G, Mogensen CE, Groop LC, Pauls JF: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetic patients and microalbuminuria. JAMA 1994;271:275-279.
33. Laffel LMB, McGill JB, Gans DJ: The beneficial effect of angiotensin-converting-enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995;99:497-504.
34. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin converting enzyme inhibition in non-insulin dependent diabetes mellitus. Arch Intern Med 1996;156:286-289.
35. Trevisan R, Tiengo A: Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive noninsulin dependent diabetic patients. Am J Hypertens 1995;8:876-883.
36. Ruggenenti P, Remuzzi G: Anti-hypertensive agents and incipient diabetic nephropathy; in Marshall SM, Home PD, Rizza RA (eds): The Diabetes Annual/9. 1995, pp 295-317.
37. Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, Carraro A, Tonolo G, Fresu P, Cernigoi AM, Fioretto P, Nosadini R: Effects of cilazapril and amlodipin on kidney function in hypertensive NIDDM patients. Diabetes 1996;45:216-222.
38. Mosconi L, Ruggenenti P, Perna A, Mecca G, Remuzzi G: Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes. Kidney Int 1996;suppl 55:S91-S93.
39. Sawicki PT, Muhlhauser I, Didiurgeit U, Baumgardner A, Bencer R, Berger M: Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens 1995;13: 933-938.
40. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LC, King AJ, Klahr S, Massry SG, Seifter JL for the Modification of Diet in Renal Disease (MDRD) Study Group. Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med 1995;123:754-762.
41. Weidmann P, Schneider M, Bohlen L: Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis. Nephrol Dial Transplant 1995;10(suppl 9):39-45.
42. Bohlen L, de Courten M, Weidmann P: Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 1994; 7:84S-92S.